Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725774 | SCV000339292 | uncertain significance | not provided | 2016-02-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083481 | SCV000650206 | benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000304342 | SCV000717650 | likely benign | not specified | 2017-03-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Revvity Omics, |
RCV000725774 | SCV003817424 | uncertain significance | not provided | 2022-04-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000725774 | SCV004156389 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | PLEC: BP4 |